BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8497274)

  • 1. Activation of the myc oncoprotein leads to increased turnover of thrombospondin-1 mRNA.
    Janz A; Sevignani C; Kenyon K; Ngo CV; Thomas-Tikhonenko A
    Nucleic Acids Res; 2000 Jun; 28(11):2268-75. PubMed ID: 10871348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype.
    Ngo CV; Gee M; Akhtar N; Yu D; Volpert O; Auerbach R; Thomas-Tikhonenko A
    Cell Growth Differ; 2000 Apr; 11(4):201-10. PubMed ID: 10775037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.
    Grandori C; Mac J; Siëbelt F; Ayer DE; Eisenman RN
    EMBO J; 1996 Aug; 15(16):4344-57. PubMed ID: 8861962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of avian leukosis virus long terminal repeat-enhanced transcription by C/EBP-Rel interactions.
    Bowers WJ; Baglia LA; Ruddel A
    J Virol; 1996 May; 70(5):3051-9. PubMed ID: 8627783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apparent uncoupling of oncogenicity from fibroblast transformation and apoptosis in a mutant myc gene transduced by feline leukemia virus.
    Fulton R; Gallagher R; Crouch D; Neil JC
    J Virol; 1996 Feb; 70(2):1154-62. PubMed ID: 8551576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis.
    Lutterbach B; Hann SR
    Mol Cell Biol; 1994 Aug; 14(8):5510-22. PubMed ID: 8035827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA binding by the Myc oncoproteins.
    Kato GJ; Wechsler DS; Dang CV
    Cancer Treat Res; 1992; 63():313-25. PubMed ID: 1363364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYC protein interactors in gene transcription and cancer.
    Lourenco C; Resetca D; Redel C; Lin P; MacDonald AS; Ciaccio R; Kenney TMG; Wei Y; Andrews DW; Sunnerhagen M; Arrowsmith CH; Raught B; Penn LZ
    Nat Rev Cancer; 2021 Sep; 21(9):579-591. PubMed ID: 34188192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overproduction of v-Myc in the nucleus and its excess over Max are not required for avian fibroblast transformation.
    Tikhonenko AT; Hartman AR; Linial ML
    Mol Cell Biol; 1993 Jun; 13(6):3623-31. PubMed ID: 8497274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gag as well as myc sequences contribute to the transforming phenotype of the avian retrovirus FH3.
    Tikhonenko AT; Linial ML
    J Virol; 1992 Feb; 66(2):946-55. PubMed ID: 1731115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations within the 5' half of the avian retrovirus MC29 v-myc gene alter or abolish transformation of chicken embryo fibroblasts and macrophages.
    Farina SF; Huff JL; Parsons JT
    J Virol; 1992 May; 66(5):2698-708. PubMed ID: 1313895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An avian retrovirus expressing chicken pp59c-myc possesses weak transforming activity distinct from v-myc that may be modulated by adjacent normal cell neighbors.
    Filardo EJ; Humphries EH
    J Virol; 1991 Dec; 65(12):6621-9. PubMed ID: 1942247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of the carboxy-terminal transforming region of v-Myc: binding to Max is necessary, but not sufficient, for cellular transformation.
    Min S; Mascarenhas NT; Taparowsky EJ
    Oncogene; 1993 Oct; 8(10):2691-701. PubMed ID: 8378081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative forms of Max as enhancers or suppressors of Myc-ras cotransformation.
    Mäkelä TP; Koskinen PJ; Västrik I; Alitalo K
    Science; 1992 Apr; 256(5055):373-7. PubMed ID: 1566084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.
    Zervos AS; Gyuris J; Brent R
    Cell; 1993 Jan; 72(2):223-32. PubMed ID: 8425219
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.